TOPICS

Category: Psoriasis

Comparison of Guidelines for the Use of Interleukin-17 Inhibitors for Psoriasis in the United States, Britain, and Europe: A Critical Appraisal and Comprehensive Review

J Clin Aesthet Dermatol. 2021;14(6):55–59. by Donovan G. Kearns, BA; Shelley Uppal, MD; Vipawee S. Chat, BA; and Jashin J. Wu, MD Mr. Kearns is with Loma Linda University School of Medicine in Loma Linda, California. Dr. Uppal is with Albany Medical College School of Medicine in Albany, New York. Ms. Chat is with the

CONTINUE READING »

Selected Abstracts from MauiDerm 2021 for Dermatologists

J Clin Aesthet Dermatol. 2021;14(5 Suppl 1):S8–S30. © µ µ ? A message from the Guest Editor and MauiDerm Program Director, George Martin, MD Dear Colleagues:  The 2021 edition of the Maui Derm for Dermatologists meeting had a variety of clinical and scientific data presented, but not just at the podium. A wide range of clinically

CONTINUE READING »

The Psoriasis Decision Tree

J Clin Aesthet Dermatol. 2021;14(4):14–22. by George Monks, MD; Ryan Rivera-Oyola, MS; Mark Lebwohl, MD Dr. Monks is with the Department of Dermatology, University of Oklahoma College of Medicine in Oklahoma City, Oklahoma. Mr. Rovera-Oyola and Dr. Lebwohl are with the Department of Dermatology, Icahn School of Medicine at Mt. Sinai Hospital in New York,

CONTINUE READING »